Asia
At the six-month mark, 68% of participants reported at least one persistent symptom, which fell to 49% after one year.
Approximately 14,000 American women are expected to be diagnosed with invasive cervical cancer in 2021, and more than 4,000 are expected to succumb to the disease.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
BioSpace recently spoke with Yoav Kimchy, founder and chief technology officer of Check-Cap, a company developing the C-Scan® system to detect precancerous polyps.
Early data from a Phase III study for COVID-19 shows significant promise with its combo therapy reduced death and hospitalization in trial patients at high risk of progression by 78%.
The current continues as investment dollars flow into the life sciences. Here’s an overview who is catching the drift this week.
It was another busy week in clinical trial news. Here’s a look.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Junshi Biosciences announced that the Phase III clinical trial it is conducting alongside Coherus BioSciences on a potential non-small cell lung cancer drug shows positive preliminary results.
Global biopharma and life sciences companies provide updates to their businesses and pipelines.
PRESS RELEASES